Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 193

The DOI matches its Crossref record.

Reduction of synovial inflammation after anti‐cd4 monoclonal antibody treatment in early rheumatoid arthritis

Tak, Paul P., Van Der Lubbe, Peter A., Cauli, Alberto, Daha, Mohamed R., Smeets, Tom J. M., Kluin, Philip M., Meinders, A. Edo, Yanni, Ghada, Panayi, Gabriel S., Breedveld, Ferdinand C.·1995·Arthritis & Rheumatism

Abstract

Objective. To study the effect of chimeric anti‐CD4 monoclonal antibody (MAb) therapy on synovial inflammation, in order to interpret the clinical experience with anti‐CD4 treatment. Methods. The immunohistologic features of synovial biopsy specimens before and 4 weeks after anti‐CD4 MAb (cM‐T412) therapy were studied in patients with rheumatoid arthritis. The patients received intravenous doses of either placebo (n = 1) or 10 mg (n = 4), 25 mg (n = 2), or 50 mg (n = 1) of cM‐T412 daily for 5 consecutive days. Results. Although the patients did not experience clinical improvement, significant decreases in the number of circulating CD4+ cells, the degree of synovial inflammatory infiltration, and the mean scores for expression of adhesion molecules were found in the 7 patients 4 weeks after receiving cM‐T412. The scores for infiltration with CD4+ and other inflammatory cells were particularly reduced following treatment with either 25 mg or 50 mg cM‐T412. Cytokines, such as interleukin‐1β and tumor necrosis factor α, could still be detected in the synovial tissue after treatment. Conclusion. The decline in the numbers of inflammatory cells and adhesion molecules in synovial tissue after CD4+ cell depletion supports the view that CD4+ T cells orchestrate local cellular infiltration. The lack of clinical effect of anti‐CD4 therapy might be explained by an insufficient decrease in the number of synovial CD4+ cells and by the persistence of cytokines. Determination of whether more adequate dosing would lead to a clinical improvement must await further study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.1780381012

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 193

Metadata

Authors
Tak, P. P., Van Der Lubbe, P. A., Cauli, A., Daha, M. R., Smeets, T. J. M., Kluin, P. M., Meinders, A. E., Yanni, G., Panayi, G. S., & Breedveld, F. C.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
1995-10
Volume
38
Issue
10
Pages
1457-1465
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2048341382
Cited by
193
References
0
FWCI
6.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduction of synovial inflammation after anti‐cd4 monoclonal antibody treatment in early rheumatoid arthritis. https://app.cochat.ai/papers/10.1002/art.1780381012
The paper
Tak, P. P., Van Der Lubbe, P. A., Cauli, A., Daha, M. R., Smeets, T. J. M., Kluin, P. M., Meinders, A. E., Yanni, G., Panayi, G. S., & Breedveld, F. C. (1995). Reduction of synovial inflammation after anti‐cd4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780381012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.